GeneTherapyLive: Non-Viral Gene Therapy Eases Treatment Burden in Wet AMD
GeneTherapyLive: Non-Viral Gene Therapy Eases Treatment Burden in Wet AMD
GeneTherapyLive: Non-Viral Gene Therapy Eases Treatment Burden in Wet AMDhttps://eyevensys.com/wp-content/themes/crocal/images/empty/thumbnail.jpg150150EyevensysEyevensyshttps://eyevensys.com/wp-content/themes/crocal/images/empty/thumbnail.jpg
A non-viral gene therapy sustained drug-delivery product that delivers anti-VEGF to the eye may replace the need for repeated intravitreal anti-VEGF injections and improve vision in patients with wet AMD.